From: A systems biology approach to suppress TNF-induced proinflammatory gene expressions
 | Reaction | Formula and parameters (s-1) | Remarks | |||||||
---|---|---|---|---|---|---|---|---|---|---|
1 1 | TNFR1 | → | TRADD | k 1 | * | TNFR1 | k 1 | = | 5e-3 | Activation of TRADD by TNFR1 |
2 2 | TRADD | → | cIAP1/2 | k 2 | * | TRADD | k 2 | = | 2e-2 | Formation of Complex 1 containing TRADD, cIAP1/2, TRAF2, TRAF5, RIP1 and the TAB/TAK complex |
3 3 | cIAP1/2 | → | TRAF2 | k 3 | * | cIAP1/2 | k 3 | = | 1e-2 | |
4 4 | cIAP1/2 | → | TRAF5 | k 4 | * | cIAP1/2 | k 4 | = | 8e-3 | |
5 5 | TRAF2 | → | RIP1 | k 5 | * | TRAF2 | k 5 | = | 1e-3 | |
6 5 | TRAF5 | → | RIP1 | k 6 | * | TRAF5 | k 6 | = | 1e-3 | |
7 6 | TRADD | → | TRAF6 | k 7 | * | TRADD | k 7 | = | 2e-2 | Activation of TRAF6 by TRADD |
8 5 | TRAF6 | → | RIP1 | k 8 | * | TRAF6 | k 8 | = | 1e-4 | Activation of RIP1 and TAK1 complex by TRAF6 |
9 7 | TRAF6 | → | TAK1 complex | k 9 | * | TRAF6 | k 9 | = | 1.3e-4 | |
10 8 | RIP1 | → | LUBAC | k 10 | * | RIP1 | k 10 | = | 7e-3 | Complex 1 ubiquitination by LUBAC and SHARPIN |
11 9 | RIP1 | → | SHARPIN | k 11 | * | RIP1 | k 11 | = | 7e-3 | |
12 7 | LUBAC | → | TAK1 complex | k 12 | * | LUBAC | k 12 | = | 1e-1 | |
13 | SHARPIN | → | IKK complex | k 13 | * | SHARPIN | k 13 | = | 1e-2 | Activation of IKK complex by Complex 1 |
14 | TAK1 complex | → | IKK complex | k 14 | * | TAK1 complex | k 14 | = | 1e-1 | |
15 10 | IKK complex | → | IκBα | k 15 | * | IKK complex | k 15 | = | 1e-2 | Phosphorylation of IκBα by IKK |
16 | IκBα | → | NF-κBc | k 16 | * | IκBα | k 16 | = | 8e-3 | Degradation of IκBα forms NF-κB |
17 | NF-κBc | → | NF-κBn | k 17 | * | NF-κBc | k 17 | = | 1.7e-2 | Translocation of NF-κB to nucleus |
18 | TAK1 complex | → | MKK1/2 | k 18 | * | TAK1 complex | k 18 | = | 1.5e-3 | Activation of MAP kinases kinases by TAK1 complex |
19 11 | TAK1 complex | → | MKK3/6 | k 19 | * | TAK1 complex | k 19 | = | 1e-2 | |
20 | TAK1 complex | → | MKK4/7 | k 20 | * | TAK1 complex | k 20 | = | 1e-2 | |
21 | MKK1/2 | → | ERK | k 21 | * | MKK1/2 | k 21 | = | 5e-3 | Activation of MAP kinases |
22 12 | MKK3/6 | → | p38 | k 22 | * | MKK3/6 | k 22 | = | 5e-3 | |
24 | MKK4/7 | → | JNK | k 23 | * | MKK4/7 | k 23 | = | 5e-3 | |
24 | p38 | → | p38n | k 24 | * | p38 | k 24 | = | 5e-2 | Translocation of MAP kinases into nucleus |
25 | JNK | → | JNKn | k 25 | * | JNK | k 25 | = | 5e-2 | |
26 | ERK | → | ERKn | k 26 | * | ERK | k 26 | = | 5e-3 | |
27 | p38n | → | AP1 | k 27 | * | p38n | k 27 | = | 1e-2 | Activation of AP1 by MAP kinases |
28 | ERKn | → | AP1 | k 28 | * | ERKn | k 28 | = | 1e-2 | |
29 | JNKn | → | AP1 | k 29 | * | JNKn | k 29 | = | 1e-2 | |
30 | AP1 | → | GI promoter | k 30 | * | AP1 | k 30 | = | 1e-1 | Promoter binding of AP1 and NF-κB for group I genes |
31 | NF-κBn | → | GI promoter | k 31 | * | NF-κBn | k 31 | = | 5e-3 | |
32 | G1 promoter | → | GI pre-mRNA | k 32 | * | GI promoter | k 32 | = | 1e-2 | Group I genes transcription, splicing (1 step) and decay |
33 | GI pre-mRNA | → | GI mRNA | k 33 | * | GI pre-mRNA | k 33 | = | 5e-2 | |
34 | GI mRNA | → | GI mRNA decay | k 34 | * | GI mRNA | k 34 | = | 2e-3 | |
35 13 | AP1 | → | GII promoter | k 35 | * | AP1 | k 35 | = | 1.1e-2 | Promoter binding of AP1 and NF-κB for group II genes |
36 | NF-κBn | → | GII promoter | k 36 | * | NF-κBn | k 36 | = | 4e-3 | |
37 | GII promoter | → | GII pre-mRNA/1 | k 37 | * | GII promoter | k 37 | = | 2e-3 | Group II genes transcription, splicing (2 steps) and decay |
38 | GII pre-mRNA/1 | → | GII pre-mRNA/2 | k 38 | * | GII pre-mRNA/1 | k 38 | = | 5e-2 | |
39 | GII pre-mRNA/2 | → | GII mRNA | k 39 | * | GII pre-mRNA/2 | k 39 | = | 5e-2 | |
40 13 | GII mRNA | → | GII mRNA decay | k 40 | * | GII mRNA | k 40 | = | 1.2e-4 | |
41 | AP1 | → | GIII promoter | k 41 | * | AP1 | k 41 | = | 5e-3 | Promoter binding of AP1 and NF-κB for group III genes |
42 | NF-κBn | → | GIII promoter | k 42 | * | NF-κBn | k 42 | = | 1e-4 | |
43 | GIII promoter | → | GIII pre-mRNA/1 | k 43 | * | GIII promoter | k 43 | = | 1e-1 | Group III genes transcription, splicing (3 steps) and decay |
44 | GIII pre-mRNA/1 | → | GIII pre-mRNA/2 | k 44 | * | GIII pre-mRNA/1 | k 44 | = | 4e-4 | |
45 | GIII pre-mRNA/2 | → | GIII pre-mRNA/3 | k 45 | * | GIII pre-mRNA/2 | k 45 | = | 1e-3 | |
46 | GIII pre-mRNA/3 | → | GIII mRNA | k 46 | * | GIII pre-mRNA/3 | k 46 | = | 2e-4 | |
47 | GIII mRNA | → | GIII mRNA decay | k 47 | * | GIII mRNA | k 47 | = | 2e-5 | |
48 | GI mRNA | → | X1 | k 48 | * | GI mRNA | k 48 | = | 1e-5 | Feedback processes via group I genes or NF-κB |
49 | NF-κBn | → | X1 | k 49 | * | NF-κBn | k 49 | = | 5e-1 | Steps of the secondary feedback processes (cytosolic or autocrine signaling): |
50 | X1 | → | X2 | k 50 | * | X1 | k 50 | = | 2e-3 | |
51 | X2 | → | X3 | k 51 | * | X2 | k 51 | = | 2e-3 | |
52 | X3 | → | X4 | k 52 | * | X3 | k 52 | = | 2e-3 | |
53 | X4 | → | X5 | k 53 | * | X4 | k 53 | = | 2e-3 | |
54 | X5 | → | X6 | k 54 | * | X5 | k 54 | = | 2e-3 | |
55 | X6 | → | X7 | k 55 | * | X6 | k 55 | = | 2e-3 | • expression (e.g. translation) |
56 | X7 | → | X8 | k 56 | * | X7 | k 56 | = | 2e-3 | • transport (e.g. secretion) |
57 | X8 | → | X9 | k 57 | * | X8 | k 57 | = | 2e-3 | • signaling (e.g. receptor binding, activation of transcription factors) |
58 | X9 | → | X10 | k 58 | * | X9 | k 58 | = | 2e-3 | |
59 | X10 | → | X11 | k 59 | * | X10 | k 59 | = | 2e-3 | |
60 | X11 | → | X12 | k 60 | * | X11 | k 60 | = | 2e-3 | |
61 | X12 | → | X13 | k 61 | * | X12 | k 61 | = | 2e-3 | |
62 | X13 | → | X14 | k 62 | * | X13 | k 62 | = | 2e-3 | |
63 | X14 | → | IκBα | k 63 | * | X14 | k 63 | = | 2e-3 | IκBα feedback activation |
64 | X14 | → | Y | k 64 | * | X14 | k 64 | = | 1e-5 | Group III feedback activation via transcription factor Y |
65 | Y | → | GIII promoter | k 65 | * | Y | k 65 | = | 2e-3 |